YXT.COM released FY2024 Annual Earnings on March 27 After-Market EST, actual revenue USD 46 M, actual EPS USD -0.2273

Brief Summary

YXT.COM reported a revenue of 46 million USD and an EPS of -0.2273 USD for the fiscal year 2024 as of March 27, 2025.

Impact of The News

1. Earnings Performance: YXT.COM’s financial results show a negative EPS of -0.2273 USD, reflecting a loss per share and suggesting poor profitability for the fiscal year 2024. This performance indicates that the company did not meet positive expectations regarding profitability.
2. Revenue Comparison: With a revenue of 46 million USD, YXT.COM’s revenue is modest compared to other companies mentioned in the references, such as Dada Group’s 27.52 billion RMB in Q4 2023 or Modern Dental’s 3,172 million HKD for the year 2023. While direct comparisons in terms of size may not be entirely fair due to different industries and markets, the relative scale of revenue indicates YXT.COM’s position in its respective market .
3. Market Expectations: The briefing does not specify market expectations for YXT.COM, making it challenging to evaluate precisely whether these figures exceed or fall short of expectations. However, the negative EPS suggests that the company may have missed profitability expectations.
4. Business Development Trends: Given the negative EPS, YXT.COM may need to address profitability issues to ensure sustainable growth. Strategies could include cost optimization, revenue enhancement, or exploring new markets, depending on the underlying causes of the loss. Comparing this with other companies in the references with positive growth trends and profitable results may highlight areas for YXT.COM to focus on, such as operational efficiency or market expansion.
5. Broader Market Context: The performance figures of YXT.COM should be considered in the context of industry trends and economic conditions, which may impact all companies in the market. It is important for YXT.COM to align its strategies with broader economic indicators to improve its financial health.